Detalhe da pesquisa
1.
Sepax-2 cell processing device: a study assessing reproducibility of concentrating thawed hematopoietic progenitor cells.
J Transl Med
; 20(1): 503, 2022 11 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36329460
2.
Nonmyeloablative Conditioning Regimen before T Cell Replete Haploidentical Transplantation with Post-Transplant Cyclophosphamide for Advanced Hodgkin and Non-Hodgkin Lymphomas.
Biol Blood Marrow Transplant
; 26(12): 2299-2305, 2020 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-32822845
3.
Peripheral Blood Stem Cells versus Bone Marrow for T Cell-Replete Haploidentical Transplantation with Post-Transplant Cyclophosphamide in Hodgkin Lymphoma.
Biol Blood Marrow Transplant
; 25(9): 1810-1817, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31128326
4.
Thiotepa, Fludarabine, and Busulfan Conditioning Regimen before T Cell-Replete Haploidentical Transplantation with Post-Transplant Cyclophosphamide for Acute Myeloid Leukemia: A Bicentric Experience of 100 Patients.
Biol Blood Marrow Transplant
; 25(9): 1803-1809, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31128325
5.
A matched-pair analysis reveals marginally reduced CD34+ cell mobilization on second occasion in 27 related donors who underwent peripheral blood stem cell collection twice at the same institution.
Transfusion
; 59(11): 3442-3447, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31625183
6.
Mobilization and collection of CD34 + cells in patients with globin disorders: Providing the starting material to manufacturers of autologous gene therapies.
Transfus Apher Sci
; 63(3): 103926, 2024 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-38670856
7.
HLA-Matched Sibling versus Unrelated versus Haploidentical Related Donor Allogeneic Hematopoietic Stem Cell Transplantation for Patients Aged Over 60 Years with Acute Myeloid Leukemia: A Single-Center Donor Comparison.
Biol Blood Marrow Transplant
; 24(7): 1449-1454, 2018 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-29448057
8.
T Cell-Replete Haploidentical Transplantation with Post-Transplantation Cyclophosphamide for Hodgkin Lymphoma Relapsed after Autologous Transplantation: Reduced Incidence of Relapse and of Chronic Graft-versus-Host Disease Compared with HLA-Identical Related Donors.
Biol Blood Marrow Transplant
; 24(3): 627-632, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29197681
9.
Killer Cell Immunoglobulin-Like Receptor-Ligand Mismatch in Donor versus Recipient Direction Provides Better Graft-versus-Tumor Effect in Patients with Hematologic Malignancies Undergoing Allogeneic T Cell-Replete Haploidentical Transplantation Followed by Post-Transplant Cyclophosphamide.
Biol Blood Marrow Transplant
; 24(3): 549-554, 2018 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29247781
10.
Effect of Azithromycin on Airflow Decline-Free Survival After Allogeneic Hematopoietic Stem Cell Transplant: The ALLOZITHRO Randomized Clinical Trial.
JAMA
; 318(6): 557-566, 2017 08 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28787506
11.
Haploidentical T Cell-Replete Transplantation with Post-Transplantation Cyclophosphamide for Patients in or above the Sixth Decade of Age Compared with Allogeneic Hematopoietic Stem Cell Transplantation from an Human Leukocyte Antigen-Matched Related or Unrelated Donor.
Biol Blood Marrow Transplant
; 22(1): 119-24, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26341397
12.
Unrelated cord blood compared with haploidentical grafts in patients with hematological malignancies.
Cancer
; 121(11): 1809-16, 2015 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-25649994
13.
Bone marrow compared with peripheral blood stem cells for haploidentical transplantation with a nonmyeloablative conditioning regimen and post-transplantation cyclophosphamide.
Biol Blood Marrow Transplant
; 20(5): 724-9, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24530426
14.
Poor outcome with nonmyeloablative conditioning regimen before cord blood transplantation for patients with high-risk acute myeloid leukemia compared with matched related or unrelated donor transplantation.
Biol Blood Marrow Transplant
; 20(10): 1560-5, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-24933658
15.
Antithymocyte globulin in reduced-intensity conditioning regimen allows a high disease-free survival exempt of long-term chronic graft-versus-host disease.
Biol Blood Marrow Transplant
; 20(3): 370-4, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24315846
16.
Prophylactic donor lymphocyte infusions after haploidentical haematopoietic stem cell transplantation for high risk haematological malignancies: a retrospective bicentric analysis of serial infusions of increasing doses of CD3+ cells.
Br J Haematol
; 185(3): 570-573, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30125934
17.
Reduced-toxicity conditioning prior to allogeneic stem cell transplantation improves outcome in patients with myeloid malignancies.
Haematologica
; 99(11): 1762-8, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25085356
18.
Brentuximab vedotin followed by allogeneic transplantation as salvage regimen in patients with relapsed and/or refractory Hodgkin's lymphoma.
Hematol Oncol
; 32(4): 187-91, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24301099
19.
A conditioning platform based on fludarabine, busulfan, and 2 days of rabbit antithymocyte globulin results in promising results in patients undergoing allogeneic transplantation from both matched and mismatched unrelated donor.
Am J Hematol
; 89(1): 83-7, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24108528
20.
Durable engraftment after pharmacological pre-transplant immune suppression followed by reduced-toxicity myeloablative haploidentical stem cell transplantation in highly HLA-immunized adults with sickle cell disease.
Bone Marrow Transplant
; 2024 Mar 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-38486114